Evidence map›Paper›PMID 23787489›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2014

Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.

Ashley L Doherty, Ricardo A Battaglino, Jayne Donovan, David Gagnon, Antonio A Lazzari, Eric Garshick, Ross Zafonte, Leslie R Morse

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. International Spinal Cord Injury Fracture History Extended Data Set.Topics in spinal cord injury rehabilitation · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Neurogenic Obesity and Skeletal Pathology in Spinal Cord Injury.Topics in spinal cord injury rehabilitation · 2021
    Review
  12. Observational
  13. Article
  14. The Adipokine Network in Rheumatic Joint Diseases.International journal of molecular sciences · 2019
    Review
  15. Article
  16. Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Review
  17. Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Ashley L DohertySpaulding-Harvard Spinal Cord Injury (SCI) Model System, Spaulding Rehabilitation Hospital, Boston, MA, USA.
Ricardo A Battaglino
Jayne Donovan
David Gagnon
Antonio A Lazzari
Eric Garshick
Ross Zafonte
Leslie R Morse
Harvard University · USSpaulding Rehabilitation Hospital · USBoston University · USBrigham and Women's Hospital · USVA Boston Healthcare System · US

Funding

Adiposity and Bone Loss in Spinal Cord InjuryR01AR059270 · NIAMS · SPAULDING REHABILITATION HOSPITAL · PI MORSE, LESLIE R. · 2010 to 2014
$3.0M
Bone Density and Circulating Mediators of Bone Metabolism in Chronic SCIR21HD057030 · NICHD · SPAULDING REHABILITATION HOSPITAL · PI MORSE, LESLIE R. · 2008 to 2009
$575k
Vitamin D, Respiratory Function, and Illness in Chronic SCII01RX000792 · VA · VA BOSTON HEALTH CARE SYSTEM · PI GARSHICK, ERIC · 2014 to 2016
–
NIAMS NIH HHS 1R01AR059270‐01NIAMS NIH HHS R01 AR059270NICHD NIH HHS L30 HD056721NICHD NIH HHS R21 HD057030NICHD NIH HHS R21HD057030NICHD NIH HHS R21HD057030‐02S1RRD VA I01 RX000792
6 · The paper itself

Abstract

Adipose tissue is a major regulator of bone metabolism and in the general population obesity is associated with greater bone mineral density (BMD). However, bone-fat interactions are multifactorial, and may involve pathways that influence both bone formation and resorption with competing effects on the skeleton. One such pathway involves adipocyte production of adipokines that regulate bone metabolism. In this study we determined the association between BMD, walking status, and circulating adipokines (adiponectin and leptin) in 149 men with chronic spinal cord injury (SCI). Although adipokine levels did not vary significantly based on walking status, there was a significant inverse association between adiponectin and BMD in wheelchair users independent of body composition. We found no association between adiponectin and BMD in the walkers and no association between leptin and BMD in either group. These findings suggest that for subjects with chronic SCI, walking may mitigate the effect of adiponectin mediated bone loss. For wheelchair users, adipose-derived adiponectin may contribute to SCI-induced osteoporosis because the osteoprotective benefits of obesity appear to require mechanical loading during ambulation.

Indexed as

Absorptiometry, PhotonAdiponectinAdultBiomarkersBone DensityBones of Lower ExtremityHumansLeptinMaleMiddle AgedOsteoporosisOsteoporotic FracturesSpinal Cord InjuriesWalkingWheelchairsAdiponectinBiomarkersLeptinADIPONECTINBIOMARKEROSTEOPOROSISREHABILITATION MEDICINESPINAL CORD INJURY

Identifiers

PMID23787489
PMCPMC3979427
OpenAlexW1614308627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.